1,081
Participants
Start Date
March 31, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Alisporivir
ALV 200 mg soft gel capsules administered orally
Peginterferon alfa-2a
PEG 180 μg administered via subcutaneous (s.c.) injection once weekly
Ribavirin
RBV 200 mg tablets (weight-based dose: \< 75 mg = 1000 mg/day; ≥ 75 kg = 1200 mg/day) administered orally in a divided daily dose
ALV Placebo
ALV placebo soft gel capsules administered orally
Novartis Investigative Site, Chiayi City
Novartis Investigative Site, Douliu
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Darlinghurst
Novartis Investigative Site, Westmead
Novartis Investigative Site, Kogarah
Novartis Investigative Site, Kingswood
Novartis Investigative Site, Fitzroy
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Greenslopes
Novartis Investigative Site, Kaposvár
Novartis Investigative Site, Pécs
Novartis Investigative Site, Székesfehérvár
Novartis Investigative Site, Ghent
Novartis Investigative Site, Taipei
Novartis Investigative Site, New York
Novartis Investigative Site, New York
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Brooklyn
Novartis Investigative Site, Berlin
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Genova
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Baltimore
Novartis Investigative Site, Baltimore
Novartis Investigative Site, Fairfax
Novartis Investigative Site, Incheon
Novartis Investigative Site, Newport News
Novartis Investigative Site, Kiel
Novartis Investigative Site, Pavia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Majadahonda
Novartis Investigative Site, Fayetteville
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Maitland
Novartis Investigative Site, Tampa
Novartis Investigative Site, Bradenton
Novartis Investigative Site, Padua
Novartis Investigative Site, Grenoble
Novartis Investigative Site, Khon Kaen
Novartis Investigative Site, Bologna
Novartis Investigative Site, Bologna
Novartis Investigative Site, Taichung
Novartis Investigative Site, Seville
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Cologne
Novartis Investigative Site, Mainz
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Springfield
Novartis Investigative Site, St Louis
Novartis Investigative Site, St Louis
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Omaha
Novartis Investigative Site, Lyon
Novartis Investigative Site, Dallas
Novartis Investigative Site, Arlington
Novartis Investigative Site, Houston
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Napoli
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Salt Lake City
Novartis Investigative Site, Songkhla
Novartis Investigative Site, Palermo
Novartis Investigative Site, Beverly Hills
Novartis Investigative Site, San Diego
Novartis Investigative Site, Clichy
Novartis Investigative Site, San Diego
Novartis Investigative Site, San Diego
Novartis Investigative Site, Ventura
Novartis Investigative Site, Oakland
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Craiova
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Iași
Novartis Investigative Site, Iași
Novartis Investigative Site, Shreveport
Novartis Investigative Site, Newark
Novartis Investigative Site, Dallas
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Rosario
Novartis Investigative Site, Rosario
Novartis Investigative Site, Calgary
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Downsview
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Toronto
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Hong Kong
Novartis Investigative Site, Hanoi
Novartis Investigative Site, Ho Chi Minh City
Novartis Investigative Site, Békéscsaba
Novartis Investigative Site, Roma
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Bydgoszcz
Novartis Investigative Site, Chorzów
Novartis Investigative Site, Kielce
Novartis Investigative Site, Lódz
Novartis Investigative Site, San Juan
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Busan
Novartis Investigative Site, Yangsan
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Kyunggi
Novartis Investigative Site, Busan
Novartis Investigative Site, Pusan
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Birmingham
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Newcastle upon Tyne
Novartis Investigative Site, Nottingham
Lead Sponsor
Debiopharm International SA
INDUSTRY